本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Reviva Pharmaceuticals Holdings, Inc.

0.8669
-0.0057-0.65%
盤後0.90000.0331+3.82%19:58 EDT
成交量:34.62萬
成交額:30.19萬
市值:4,051.89萬
市盈率:-0.96
高:0.9170
開:0.8818
低:0.8511
收:0.8726
資料載入中...
2021/03/22

重要事件披露

8-K - Current report
2021/03/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/04

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K/A [Amend] - Current report
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/18

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/12/14

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/12/09

重要事件披露

8-K - Current report
2020/11/19

企業合併公告

425 - Prospectuses and communications, business combinations
2020/11/19

重要事件披露

8-K - Current report
2020/11/13

重要事件披露

8-K - Current report